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To the editor: 
CRISPR-Cas9 and related technologies can efficiently alter genomic DNA at targeted 
positions and have far-reaching implications for functional screening and therapeutic gene 
editing. Understanding and unlocking this potential requires accurate evaluation of editing 
efficiency. Here, we show that methodological decisions for analyzing sequencing data can 
significantly affect mutagenesis efficiency estimates and we provide a comprehensive R-based 
toolkit, CrispRVariants and an accompanying web tool CrispRVariantsLite, that resolve and 
localize individual mutant alleles with respect to the endonuclease cut site. CrispRVariants-
enabled analyses of newly generated and existing genome editing datasets underscore how careful 
consideration of the full variant spectrum gives insight toward effective guide and amplicon design 
as well as the mutagenic process. 
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After the induction of a double strand break by Cas9 or other enzymes1,2 (coupled with a 
predesigned guide RNA), typically, a number of bases are inserted or deleted in a stochastic 
manner as the two DNA ends are rejoined by non-homologous end joining (NHEJ)3. Optionally, 
donor DNA can be introduced and integrated between the breakpoints4, 5. The result is an 
“edited” genome sequence at a chosen location. 
 
 
In vivo CRISPR applications, where multiple cells undergo independent rounds of muta- 
genesis and local NHEJ, generate particularly heterogenous sequencing data sets. Existing tools 
for the analysis of mutagenesis sequencing data report aggregated variant summaries (CRISPR- 
GA8, CRISPResso9) and are unsuited for applications that consider the entire, complex mutation 
spectrum, e.g.  quantifying mosaicism10  and allele-specific genome editing11.  To facilitate such 
analyses, we have developed CrispRVariants, an R-based toolkit for quantifying and visualising 
individual variant alleles from either traditional Sanger sequencing or high-throughput CRISPR- 
Cas9 mutagenesis sequencing experiments. CrispRVariants can be easily used to create a variant 
allele summary plot (Figure 1) and accompanying table of counts. Individual variants can be re- 
moved, allowing allele-specific analysis and adjustment for heterozygosity. By localizing variant 
alleles with respect to the nuclease cut site instead of the PCR amplicon, CrispRVariants enables 
immediate comparison of variant spectra between target locations (Supplementary Note 1). This 
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level of resolution enables users to directly relate variant genotypes to observed phenotypes and 
predict downstream effects of variants, such as protein structural changes or loss or gain of tran- 
scription factor binding sites when targeting non-coding sites (see examples in the CrispRVariants 
User Guide). Figure 1 summarizes several zebrafish embryos injected with an sgRNA targeting 
ENSDARG00000079624 (wtx), which results in a variety of alleles, some of which reoccur 
independently in multiple embryos. Notably, visualization of variant alleles facilitates the 
detection of sequencing or alignment errors and previously-unknown genetic variation. We 
designed CrispRVariants with interactivity in mind, explicitly allowing users to detect prob- 
lems and filter sequences appropriately before estimating mutation efficiency. The accompanying 
web tool, CrispRVariantsLite, which is suitable for smaller-scale experiments, can be accessed 
via the website or downloaded and run locally, allowing users without bioinformatics expertise to 
examine and plot their data. 
 
 
Distinguishing low-frequency mutation events from sequencing errors is challenging. In 
Supplementary Note 2, we show examples of sequencing errors and alignment uncertainty that 
affect the size, placement and ultimately variant classification (i.e., whether in-frame or not) of 
two germline mutant cohorts.  Sequencing errors and genetic variation confound mutation 
efficiency estimation; for example, sequence polymorphisms in the targeted locus affect sgRNA 
binding and may lead to underestimation of the true editing efficiency.  In Supplementary Note 
3, we highlight unappreciated genetic variation in a recent study12 as well as off-target sgRNAs 
that lack a canonical PAM sequence. We show through simulation that CrispRVariants matches 
or outperforms existing tools in estimating mutation efficiency (Supplementary Note 4). Notably, 
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data processing decisions invisible to users contribute substantially to the differences between 
CrispRVariants and other available tools. We include with CrispRVariants a small synthetic 
benchmarking data set containing several types of commonly observed variants to facilitate 
transparent data processing. 
 
 
Despite overwhelming evidence that data preprocessing choices affect variant calling in ex- 
ome and whole-genome sequencing studies13–15, their role in estimating mutagenesis efficiency has 
been largely neglected. Amplicon sequencing data may be aligned locally to the expected amplicon 
sequence (e.g. Gagnon et al.5, CRISPR-GA8, CRISPResso9), in which case pooled reads must 
first be separated, or globally to an entire reference genome (AmpliconDIVider16, CrispRVari- 
ants). Strategies that combine local and global alignment (CRISPResso (Pooled)9) or avoid sep- 
arating reads by aligning to the set of all amplicons17 are also possible. Inappropriate alignment 
and preprocessing settings can have a significant impact on allele counts and efficiency estimates. 
In the most extreme case, tandem repeats and homology within an amplicon resulted in efficiency 
estimates that differed by 91% between methods (Supplementary Note 5). Local alignment strate- 
gies are vulnerable to mis-counting off-target reads. For example, BLAT18 local alignment (used in 
CRISPR-GA) can result in efficiency estimates that differ by more than 30% from estimates from 
global alignments (Supplementary Note 5). Stringency criteria when merging paired-end reads or 
dividing reads by PCR primers (as done in Shah et al.12) can further affect mutation efficiency 
estimates (Supplementary Notes 6 and 7).  Specifically, altering the percentage overlap required 
for merging from 100% (as in Shah et al.12) to 90% changed the efficiency estimate for one guide 
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by 65%.  CrispRVariants separates data preprocessing from mutation quantification, allowing 
critical parameters to be carefully selected and tailored to the experimental design (see Methods). 
By aggregating variant alleles instead of looking at and interpreting the full observed spectrum, 
existing tools make it difficult to assess whether appropriate bioinformatic decisions (alignment, 
merging, separation of reads) have been made; CrispRVariants facilitates this visual, interactive 
and iterative process. 
 
 
In summary, the CrispRVariants package offers precise, transparent and reproducible pre- 
processing of low- and high-throughput amplicon sequencing experiments, providing easy visu- 
alizations of variant alleles across samples and allows careful calculation of the efficiency, given 
all the complexities and confounders. The framework can also readily be applied to other 
mutagenesis systems. The software is available from Bioconductor19 








See Supplementary Note for the availability of CrispRVariants, CrispRVariantsLite and code 
for the analyses in this paper. 
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For both low- or high-throughput sequencing analysis, the main entry point to CrispRVari- 
ants is a set of sequences aligned to a reference genome in BAM (binary alignment) format. Reads 
that cannot be represented as a single linear alignment are instead represented by some alignment 
tools as multiple “chimeric” alignments. We find that some chimeric reads are genuine variants 
(Supplementary Note 8) and recommend the use of a chimera-aware aligner. In current pipelines, 
we use BWA MEM20 with default parameters. The choice of aligner can substantially affect the 
mutation efficiency estimates (Supplementary Note 5).  Applied Biosystems Sanger sequencing 
data, commonly available in AB1 file format, can be easily converted to FASTQ format for map- 
ping; CrispRVariants uses the sangerseqR21 package to perform this conversion. The entry points 
for CrispRVariantsLite include a ZIP file of BAM files (sets of already mapped reads), a ZIP file 
of directories with AB1 files or a ZIP file of FASTQ files (file size restrictions apply). 
 
CrispRVariants can work directly with pooled amplicon sequencing data.  Reads are as- 
signed to the correct amplicon either by an alignment spanning the amplicon region almost exactly 
(strict), or by any base mapped to the unique portion of an amplicon (relaxed). Because of high 
error frequency, the endpoints of Illumina MiSeq data are often clipped by aligners. We extrapolate 
the mapped region to include clipped regions when matching amplicons. This dividing strategy is 
suitable for paired-end reads where both reads span the entire amplicon, or for merged paired-end 
reads. In cases where unique mapping to a single amplicon is insufficient to assign reads, align- 
ments may be filtered in R and passed directly to CrispRVariants as a GenomicAlignments22 
object. CrispRVariants can collapse paired reads by checking for concordant variants in the vicin- 
ity of the cut site.  However, if merging criteria are not overly strict, we find that merging reads 
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prior to mapping improves speed without affecting efficiency estimates (Supplementary Note 6). 
Chimeric reads are assigned to all overlapping amplicons, however, to be counted as a variant the 
mapped endpoint of one aligned segment must be close to the specified cut site.  This criterion 
excludes PCR artifacts, such as primer dimers. Chimeric read sets are grouped into an “Other” cat- 
egory. For amplicons with a non-trivial fraction of “Other” reads, additional exploratory analyses 
are available within the software (see software vignette). 
 
Once assigned, read alignments are narrowed to the target region (i.e., the user-specified 
local genomic region around the guide’s target site). Reads that do not span the target region are 
discarded and reads that match the reference sequence are recorded as “no variant”.  Insertions 
and deletions (indels) are then localized in a strand-aware manner, labeled and counted; a 3 base 
pair deletion starting 2 bases upstream of the target location is designated “-2:3D”. Downstream 
variants are numbered similarly by their leftmost base.  Reads that do not contain an indel can 
additionally be separated by the presence of single nucleotide variants (SNVs).  By default, the 
zero point is at base 17 of a 23 bp sgRNA, i.e.  the endonuclease cut site.  The user is free to 
specify: i) the target region; ii) the corresponding zero point; and iii) a window within the target 
region for calling SNVs. 
 
Supplementary analyses For the Supplementary analyses, we use data from Shah et al.12, Burger 
et al.23  and Cho et al.24.   The performance of CrispRVariants (version 0.9.11), 
CRISPResso (version 0.9.1), CRISPR-GA and AmpliconDIVider was compared under a range 
of scenarios. Where not otherwise specified, the data is from Shah et al.; CrispRVariants and 
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Figure  1.    The CrispRVariants plotVariants function summarizes variant  types,  lo- 
cations and frequency across multiple clones from several injected  animals. This function 
returns a ggplot2-based allele summary plot consisting of (1) a schematic of the target 
site  location  relative  to the  neighboring transcripts, (2) an  alignment of the  consensus 
sequence for each variant  combination to the  reference sequence, and  (3) a heat  map 
showing  the frequency of the variants across samples (the heatmap can  be plotted  also 
with frequencies). Inserted sequences are  shown  below the alignments, with large inser- 
tions indicated  by the  corresponding symbol.   In this example, columns in the  heat  map 
represent sequences cloned  from different  embryos, with column  labels  colored  by the 
embryonic phenotype (black = uninjected, blue = wild-type-like, orange = developmental 
abnormalities or “monsters”,  green = heart  phenotype). 
Figure 1
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